CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-26 | Lundberg Sven Ante Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-05-26 | Beckman Daniella Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-05-26 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-08 | ANG ROBERT President and CEO | Shares withheld for taxes | −2,361 | $4.14 | $10K | 698,304 |
| 2023-05-08 | Chakraborty Tirtha Chief Scientific Officer | Shares withheld for taxes | −875 | $4.14 | $4K | 141,279 |
| 2023-05-08 | Jorgensen Nathan D. Chief Financial Officer | Shares withheld for taxes | −834 | $4.14 | $3K | 153,625 |
| 2023-05-08 | Attar Eyal C. Chief Medical Officer | Shares withheld for taxes | −969 | $4.14 | $4K | 53,531 |
| 2023-03-01 | ANG ROBERT President and CEO | Shares withheld for taxes | −12,657 | $5.51 | $70K | 700,665 |
| 2023-03-01 | Chakraborty Tirtha Chief Scientific Officer | Shares withheld for taxes | −5,576 | $5.51 | $31K | 142,154 |
| 2023-03-01 | Jorgensen Nathan D. Chief Financial Officer | Shares withheld for taxes | −6,310 | $5.51 | $35K | 154,459 |
| 2023-02-06 | ANG ROBERT President and CEO | Grant or award | +128,750 | 713,322 | ||
| 2023-02-06 | ANG ROBERT President and CEO | Grant or award · Employee Stock Option (right to buy) | +257,500 | 257,500 | ||
| 2023-02-06 | Attar Eyal C. Chief Medical Officer | Grant or award | +54,500 | 54,500 | ||
| 2023-02-06 | Attar Eyal C. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +109,000 | 109,000 | ||
| 2023-02-06 | Jorgensen Nathan D. Chief Financial Officer | Grant or award | +45,500 | 160,769 | ||
| 2023-02-06 | Jorgensen Nathan D. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +91,000 | 91,000 | ||
| 2023-02-06 | Chakraborty Tirtha Chief Scientific Officer | Grant or award | +47,750 | 147,730 | ||
| 2023-02-06 | Chakraborty Tirtha Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +95,500 | 95,500 | ||
| 2022-12-09 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +11,627,907 | $4.30 | $50.0M | 20,923,554 |
| 2022-10-11 | Attar Eyal C. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +364,000 | 364,000 |
Page 14 of 18 · 344 trades